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Abstract
This study examines the relationship between common genetic variation within DNA methyltransferase genes and
inter-individual variation in DNA methylation. Eleven polymorphisms spanning DNMT1 and DNMT3B were
genotyped. Global and gene specific (IGF2, IGFBP3, ZNT5) DNA methylation was quantified by LUMA and bisulfite
Pyrosequencing assays, respectively, in neonatal cord blood and in maternal peripheral blood. Associations between
maternal genotype and maternal methylation (n ≈ 333), neonatal genotype and neonatal methylation (n ≈ 454), and
maternal genotype and neonatal methylation (n ≈ 137) were assessed. The findings of this study provide some
support to the hypothesis that genetic variation in DNA methylating enzymes influence DNA methylation at global and
gene-specific levels; however observations were not robust to correction for multiple testing. More comprehensive
analysis of the influence of genetic variation on global and site specific DNA methylation is warranted.
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Introduction
DNA methylation is an epigenetic mechanism that plays an
important role in gene expression [1], tissue differentiation [2]
and genomic imprinting [3]. Addition of methyl groups to the 5’
position on cytosine residues in DNA is mediated by the family
of DNA methyltransferase (DNMT) proteins, including DNMT1,
DNMT3A, DNMT3B and DNMT3L. DNMT1 plays a major role
in the maintenance of methylation patterns, exhibiting a higher
level of activity on hemi-methylated, compared with
unmethylated, DNA [4]. De novo methylation is catalysed by
DNMT3A and DNMT3B. DNMT3L is also involved in de novo
methylation through binding to DNMT3A and DNMT3B and via
its ability to recognise the modification status of other
epigenetic marks including histone proteins [5].
Whilst numerous studies have implicated environmental and
lifestyle factors in inter-individual variation in DNA methylation
patterns in humans [6,7], considerably less is known about the
role of common genetic variation [8-10]. Longitudinal analysis
of DNA methylation, where blood samples were taken
approximately 16 years apart, found familial clustering in the
degree of change in DNA methylation levels over time [11],
suggesting that the maintenance of epigenetic patterns is partly
under genetic control. Genetic determinants of DNA
methylation in individuals may therefore make an important
contribution to variance in this trait and potentially to a range of
phenotypes including disease risk.
In animal models, genetic manipulation of DNMT genes
demonstrates clearly their essential role in development with
knockouts of DNMT1 and DNMT3B being embryonic lethal in
mice [12,13]. A number of human monogenic disorders result
from mutations in these genes [14]. For example, mutations in
exon 20 and 21 of DNMT1 result in the autosomal dominant
hereditary sensory and autonomic neuropathy type 1 while
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DNMT3 mutations result in the recessive immunodeficiency
centromeric instability facial syndrome 1. In addition, common
genetic variants spanning the DNMT genes have been
associated with several complex phenotypes. For example,
there are associations between DNMT3B genotype, breast
cancer susceptibility, lung cancer susceptibility and prostate
cancer progression [15-17]. Although the exact mechanisms
through which these DNMT mutations cause the corresponding
pathogenic phenotypes are not fully understood, they have
been associated with altered global DNA methylation levels
[14,18]. Furthermore, single nucleotide polymorphisms (SNPs)
in DNMT genes have been associated with functional variation
i.e. altered activity of the encoded protein [16,19,20], which is
postulated to cause aberrant methylation patterns. However,
most studies investigating the effects of DNMT gene
polymorphisms on downstream DNA methylation patterns have
been in the context of disease phenotypes rather than a
general population based cohort.
We hypothesised that genetic variants within genes
responsible for maintenance of DNA methylation (DNMT1) and
for de novo DNA methylation (DNMT3B) alter methylation
profiles at specific loci and, more so, influence levels of global
DNA methylation. We tested this hypothesis in samples taken
from adult women and their neonatal offspring from the North
Cumbria Community Genetics Project (NCCGP) [21]. Since the
influence of environmental and lifestyle exposures on DNA
methylation patterns may increase over time [22] such potential
confounding may be minimised in the neonates. In addition,
given the evidence for inter-generational influences on DNA
methylation patterns [23,24] we also considered the secondary
hypothesis that maternal DNMT genotype influence DNA
methylation patterns in their neonatal offspring.
Materials and Methods
Study population
Peripheral blood DNA samples were available for 333
mothers along with cord blood DNA samples from 454
neonates, including 137 mother-child pairs. These subjects
were recruited as part of the NCCGP, between 1996 and 2003,
at a single maternity unit in West Cumbria, UK [21]. Mothers
completed a detailed questionnaire and provided blood
samples during their first antenatal clinic (mean (SD) gestation
= 11.3 (5.4) weeks). Cord blood from neonates was collected at
birth (mean (SD) gestation = 39.5 (1.4) weeks). Written
informed consent was obtained from all participating mothers
recruited during pregnancy. The consent obtained included use
of their own biological samples and those of their child
(including DNA) for epidemiological studies. Ethical approval to
undertake this study was obtained from the Cumbria and
Lancashire Local Research Ethics Committee.
Genotype analysis for DNMT1 and DNMT3B
Eleven SNPs spanning the DNMT1 and DNMT3B genes
were genotyped across all study samples by K-Bioscience
using their proprietary KasPar system
(www.kbioscience.co.uk/). These included 2 pairwise tagging
SNPs for DNMT1 (rs2290684, rs2241531) and 8 pairwise
tagging SNPs for DNMT3B (rs6119954, rs992472, rs2424928,
rs2424932, rs6058897, rs437302, rs406193) as described
previously by Cebrian et al [15]. In addition, two DNMT3B
SNPs (rs1569686, rs2424913) located within the promoter/5'
gene region and previously associated with altered promoter
activity were selected for investigation [16,19,25,26].
Polymorphisms demonstrating genotyping success rates less
than 80% and minor allele frequencies (MAF) less than 5%
were removed prior to analysis. Hardy Weinberg Equilibrium
(HWE) was assessed for each SNP; those demonstrating
deviations from HWE (P < 0.05) were removed prior to
analysis.
LUMA assay to determine global DNA methylation
Genomic DNA methylation was measured as part of our
previously published study [27] and was available for a subset
of individuals in the current analysis (Table 1). The
luminometric methylation assay (LUMA) protocol has been
described in detail previously [27,28]. Briefly, 200ng DNA was
incubated for 4h at 37°C with 1) methylated (EcoRI plus MspI)
and 2) unmethylated (EcoRI plus HpaII) restriction enzyme sets
in 20µl volume reactions containing 5 units of each enzyme
(New England Biolabs) and 2µl of Tango buffer (Fermentas).
Digests were carried out in triplicate for each sample and
analysed by Pyrosequencing on a Pyromark™ MD system.
Data are presented as a methylation ratio (defined as (HpaII/
EcoRI)/(MspI/EcoRI)) with a higher ratio indicative of less
methylated DNA.
Bisulfite Pyrosequencing for candidate gene DNA
methylation analysis
In addition to global methylation three candidate genes,
namely IGF2, IGFBP3 and ZNT5, were selected for analysis.
These genes were selected as they represent three contrasting
degrees of methylation; IGF2 is an imprinted locus with mean
methylation ~50%, IGFBP3 is constitutively methylated at low
levels (~5%) and ZNT5 is constitutively methylated at high
levels (~90%). Furthermore, we have previously shown that
DNA methylation levels at these three loci are variable and
influenced by a combination of genetic and environmental
factors [27].
Methylation levels at the three candidate loci were measured
using bisulfite Pyrosequencing as part of our previously
published study [27] and made available for the current
analysis. Table 1 reports the number of CpG sites and the
number of samples assessed for the three loci.
Pyrosequencing and quality control (QC) methods were
described in detail previously [27]. Briefly, bisulfite conversion
of 2µg of genomic DNA was performed using EZ DNA
Methylation Gold™ kit (Zymo Research) following the
manufacturer’s protocol. Quantitative bisulphite
Pyrosequencing (Qiagen, UK) with Pyro Q-CpG™ Software
(version 1.0.6.) was subsequently used to determine the
percentage methylation at individual CpG sites within the
differentially methylated region (DMR) of IGF2 (NG_008849.1;
6098-6375), the IGFBP3 promoter (NT_007819.17;
45951336-45951104) and the ZNT5 promoter (NT_006713.15;
18983340-18983714). 0.2µg of bisulfite treated DNA was
Genetic Influences on DNA Methylation
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added to the first PCR reaction with 12.5µl Hot Star Taq
mastermix (Qiagen) and optimised primer concentrations.
Complete primer and PCR conditions are described in Table
S1 in File S1. Subsequent sequencing reactions followed the
manufacturer’s protocol. Assays were assessed for
amplification bias and reliability as described previously
[27,29]. Zero and 100% in vitro methylated controls were run
routinely alongside samples as internal controls.
CpG sites with poor success rates across the study
population (<80% success) were removed prior to analysis.
Similarly, CpG sites demonstrating extreme measures of
methylation with limited variability across the study population
(median methylation = 0% or 100%) were dropped prior to
analysis. The genotypic and methylation data can be made
available upon request to the authors.
Data analysis
Linkage disequilibrium (LD) between genetic variants was
assessed using Haploview software [30]. Correlation in
methylation levels at individual CpG sites spanning the 3
candidate loci was assessed using non-parametric Spearman’s
rank correlation. Those loci demonstrating at least modest
correlation (rho > 0.6) across individual CpG sites were also
analysed using the mean percentage methylation for that locus.
Non-parametric tests for trend were performed to explore
relationships between methylation levels and SNPs under an
additive model. Polymorphisms with low MAF (i.e. <0.15) were
analysed under a dominant model, with respect to the minor
allele, using Kruskal Wallis tests. Comparisons between
methylation levels in maternal-infant pairs were made by non-
parametric Spearman’s rank correlation and Wilcoxon signed-
rank tests. Uncorrected p-values are presented throughout with
p ≤ 0.05 considered statistically significant. Corrections were
applied post hoc when interpreting the results to assess
whether nominally significant observations were robust to
correction for multiple testing. Bonferroni as well as Benjamini
and Hochberg corrections were applied in this context. All
statistical analyses were performed in Stata (version 10,
Statacorp).
Power of the study to detect associations between
DNMT genotype and DNA methylation
With 333 maternal samples, there was 94% power to detect
a 1.4 fold change in global methylation assuming an additive
model with a 5% MAF at the 0.05 significance level. This power
calculation was based on data reported previously [27] in which
the mean (SD) methylation ratio across maternal samples was
0.46 (0.3). Under the same model there was 84% power to
detect an absolute change of 4% in IGF2 methylation, 87%
power for an absolute change of 4% in IGFBP3 methylation
and 81% power for an absolute change of 6% in ZNT5
methylation. Again these calculations were based on previously
reported data in which the mean (SD) methylation percentages
for IGF2, IGFBP3 and ZNT5 were 45 (8)%, 7 (7)%, 90 (12%),
respectively [27]. There was greater power to detect the same
effects in the larger neonate cohort (n=454). Power calculations
were performed in Quanto [31,32].
Results
Cohort characteristics
Peripheral blood DNA samples were available for 333
mothers along with cord blood DNA samples from 454
neonates. The average age at the time of sample collection
from the mothers was 29 years and 52% of the neonates were
male (see Table S2 in File S1). In addition, these samples
Table 1. Global and loci specific methylation levels and correlation.
 Mothers Average Correlation† Infants Average Correlation†
Methylation locus Success Rate* Median (25%, 75%) Methylation rho p Success Rate* Median (25%, 75%) Methylation rho p
Global, ratio 213/286 (74%) 0.32 (0.27, 0.44)   320/356 (90%) 0.36 (0.31, 0.41)   
IGF2 Site1 311/326 (95%) 42.47 (38.62, 45.32)   405/423 (96%) 45.40 (41.85, 48.15)   
IGF2 Site2 309/326 (95%) 49.64 (46.34, 52.91) 0.81 <0.001 403/423 (95%) 51.98 (49.56, 54.78) 0.82 <0.001
IGF2 Site3 304/326 (93%) 47.30 (44.38, 49.86)   409/423 (97%) 50.11 (47.20, 52.28)   
IGF2 Mean 326 46.38 (43.31, 48.97)   423 49.35 (46.43, 51.55)   
IGFBP3 Site1 244/244 (100%) 5.56 (3.94, 6.91)   322/326 (99%) 4.85 (4.03, 5.75)   
IGFBP3 Site2 244/244 (100%) 6.23 (5.18, 7.54)   323/326 (99%) 5.95 (5.30, 6.72)   
IGFBP3 Site3 244/244 (100%) 4.98 (4.15, 6.16) 0.77 <0.001 322/326 (99%) 4.43 (3.92, 5.18) 0.64 <0.001
IGFBP3 Site4 242/244 (99%) 8.25 (7.04, 9.51)   324/326 (99%) 7.42 (6.55, 8.24)   
IGFBP3 Site5 243/244 (100%) 6.17 (4.99, 7.52)   319/326 (98%) 6.55 (5.64, 7.64)   
IGFBP3 Mean 244 6.25 (5.12, 7.36)   326 5.83 (5.24, 6.59)   
ZNT5 Site2 215/218 (99%) 90.00 (79.50, 95.00) 0.26 <0.001 341/350 (97%) 94.50 (88.00, 97.00) 0.24 <0.001
ZNT5 Site3 212/218 (97%) 92.00 (85.00, 95.50)   342/350 (98%) 96.25 (89.50, 99.00)   
ZNT5 Site4 173/218 (79%) 100 (97.50, 100) Excluded 304/350 (87%) 100 (98.00, 100) Excluded
ZNT5 Site5 139/218 (64%) 69.50 (64.00, 85.50) Excluded 263/350 (75%) 70.50 (63.50, 90.00) Excluded
ZNT5 Site6 48/218 (22%) 84.00 (79.75, 86.00) Excluded 161/350 (46%) 80.50 (74.50, 83.50) Excluded
* Global and loci specific methylation data was not available for all subjects. † Correlation assessed by nonparametric Spearman’s rank.
doi: 10.1371/journal.pone.0076506.t001
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comprised 137 mother-child pairs. These pairs were
representative of their larger sample groups (see Table S2 in
File S1). SNPs mapping to the DNMT1 and DNMT3B genes
were genotyped across all samples. Pyrosequencing data was
previously generated on smaller subsets of these samples
(Table 1).
Genotype data across the DNMT1 and DNMT3B genes
Eleven SNPs, with MAF >0.05, were genotyped successfully
in both neonates and adult women (Figure 1). Three of these
SNPs (DNMT1 rs2241531, DNMT3B rs437302 and rs406193)
had relatively low MAF (<0.15) and underwent exploratory
analyses using a dominant rather than an additive model. One
DNMT3B SNP (rs6119954) did not conform to HWE (p =
0.003) in the neonate group and was excluded from further
analysis. The two putative functional SNPs rs1569686 and
rs2424913 demonstrated strong LD (r2>0.8) with the DNMT3B
rs992472 and rs2424928 tagging SNPs (Figure 1). In total, 10
SNPs were taken forward for analysis.
Correlation between CpG sites within the IGF2, IGFBP3
and ZNT5 genes
In addition to global methylation, methylation of 3 CpG sites
in the DMR of the imprinted gene IGF2 and 5 CpG sites in both
the IGFBP3 and ZNT5 promoter regions was quantified (Table
1). CpG site 4 in ZNT5 was very highly methylated with little
inter-individual variation (median methylation = 100%) and was
excluded from further statistical analysis. CpG sites 5 and 6 in
ZNT5 were dropped from further statistical analysis due to poor
success rates (<80%) in both maternal and neonate samples.
The remaining CpG sites (3 within IGF2, 5 within IGFBP3 and
2 with ZNT5) demonstrated high success rates in both
maternal and neonate samples (Table 1) and were taken
forward for analysis. In addition, there were modest to strong
correlations (average rho: 0.64-0.82) demonstrated between
methylation levels at the CpG sites mapping to the IGF2 and
the IGFBP3 loci in both mothers and infants (Table 1). Hence,
mean methylation levels across these two loci were calculated
and these means were also used in further analyses. Weaker
correlations (rho<0.6) were found between methylation levels
of the CpG sites measured within the ZNT5 locus therefore
only methylation values for individual CpG sites were assessed
further. Measurement of global DNA methylation was less
successful in the maternal samples (74%) compared to that in
the neonate samples (90%). However, we chose to retain this
measure for analysis but acknowledge that any findings must
be viewed with caution.
Figure 1.  Linkage disequilibrium and SNP frequencies across DNMT genes in mothers and infants.  Alleles = Major: Minor,
GT % = genotyping success rate (mothers total N = 333, infants total N = 454), MAF = minor allele frequency, HWE p = Hardy
Weinberg Equilibrium p-value. Single underscore = putative functional SNPs; strikethrough = excluded from analysis.
doi: 10.1371/journal.pone.0076506.g001
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Predictors of maternal methylation
Table 2 summarises data for those variables for which there
were statistically significant (p≤0.05) associations between
maternal genetic factors and maternal methylation levels. See
Table S3 in File S1 for all results. The minor G allele of the
DNMT1 SNP rs2290684 was associated with increased
methylation of CpG site 3 in IGF2 following an additive model.
Similar trends were demonstrated at other IGF2 CpG sites,
including the mean methylation across all CpG sites measured,
but these did not reach the p≤0.05 threshold for statistical
significance (Table S3 in File S1). Rs2290684 was also
associated with ZNT5 CpG site 3 methylation levels.
Predictors of infant methylation: infant genotypes
Table 2 summarises data for those variables for which there
were statistically significant (p≤0.05) associations between
infant genetic factors and infant methylation levels. See Table
S4 in File S1 for all results. Increased methylation at CpG sites
3 and 5 of the IGFBP3 locus was associated with the minor G
allele of the DNMT1 rs2290684 variant, whereas carriers of the
minor G allele of rs2241531 had lower methylation at CpG site
5 compared with wild-types (Table 2). Several SNPs within the
infants’ DNMT3B gene were associated with infant IGFBP3
methylation (Table 2). In particular, carriage of the minor alleles
for the putative functional SNPs (rs1569686, rs2424913) along
with the minor alleles of the pairwise tagging SNPs rs992472
and rs2424923 was accompanied by increased methylation at
CpG sites 3 and/or 5. The most statistically significant
association being demonstrated between the putative
functional SNP rs2424913 and IGFBP3 CpG site 3 (p=0.012).
In contrast, carriage of the minor alleles at both rs6058897 and
rs406193 were associated with decreased methylation at CpG
sites 3 and 5.
Table 2. Significant associations between methylation and genetic predictors.
   AA Aa aa Additive†
SNP Methylation LocusAllelesN
Median (25%, 50%)
Methylation N
Median (25%, 50%)
Methylation N
Median (25%, 50%)
Methylation Z p
Maternal Maternal          
DNMT1 rs2290684 IGF2 Site 3 A:G 81 46.25 (43.87, 48.81) 150 47.46 (44.59, 49.59) 64 48.07 (44.37, 50.73) 2.23 0.026
DNMT1 rs2290684 ZNT5 Site3 A:G 59 91.00 (81.50, 94.00) 102 93.50 (86.50, 96.50) 48 93.50 (88.00, 95.75) 2.05 0.041
Infant Infant          
DNMT1 rs2290684 IGFBP3 Site3 A:G 79 4.26 (3.74, 5.03) 167 4.39 (3.89, 4.94) 69 4.66 (4.09, 5.64) 2.45 0.014
DNMT1 rs2290684 IGFBP3 Site5 A:G 79 6.32 (5.40, 7.45) 165 6.63 (5.73, 7.56) 68 6.90 (5.97, 8.05) 2.09 0.036
DNMT1 rs2241531ɸ IGFBP3 Site5 C:G 280 6.59 (5.74, 7.69) 37 5.75 (4.18, 7.15) 0 - 5.00 0.025
DNMT3B rs1569686 IGFBP3 Site5 G:T 107 6.32 (5.61, 7.24) 158 6.68 (5.58, 7.68) 53 6.83 (5.96, 8.12) 2.03 0.042
DNMT3B rs2424913 IGFBP3 Site3 C:T 90 4.29 (3.74, 4.85) 165 4.49 (4.00, 5.29) 66 4.53 (4.03, 5.67) 2.50 0.012
DNMT3B rs2424913 IGFBP3 Site5 C:T 92 6.24 (5.49, 7.22) 160 6.57 (5.62, 7.64) 66 6.83 (5.77, 8.15) 2.23 0.026
DNMT3B rs992472 IGFBP3 Site3 C:A 114 4.30 (3.76, 4.88) 163 4.50 (3.94, 5.41) 45 4.51 (4.09, 5.15) 2.23 0.026
DNMT3B rs992472 IGFBP3 Site5 C:A 115 6.32 (5.61, 7.24) 158 6.65 (5.58, 7.68) 46 7.02 (6.07, 8.18) 2.33 0.020
DNMT3B rs2424928 IGFBP3 Site3 T:C 86 4.30 (3.75, 4.85) 167 4.49 (3.97, 5.29) 65 4.51 (4.03, 5.67) 2.16 0.030
DNMT3B rs6058897 IGFBP3 Site3 C:A 85 4.54 (4.01, 5.29) 166 4.49 (3.97, 5.32) 64 4.29 (3.81, 4.60) -2.07 0.039
DNMT3B rs6058897 IGFBP3 Site5 C:A 85 6.79 (5.77, 8.12) 161 6.55 (5.62, 7.55) 66 6.20 (5.42, 7.26) -2.05 0.040
DNMT3B rs406193ɸ IGFBP3 Site3 C:T 248 4.50 (3.99, 5.33) 66 4.29 (3.78, 4.85) 7 4.30 (3.74, 4.54) 0.53 0.021
Maternal Infant          
DNMT1 rs2241531ɸ Global C:G 81 0.35 (0.30, 0.40) 18 0.39 (0.35, 0.42) 0 - 4.35 0.037
DNMT3B rs6058897 Global C:A 27 0.36 (0.30, 0.39) 49 0.35 (0.30, 0.40) 25 0.39 (0.35, 0.41) 2.21 0.027
DNMT3B rs1569686 IGFBP3 Site1 G:T 37 3.77 (2.77, 5.36) 41 4.61 (3.70, 5.28) 17 5.09 (3.09, 6.41) 1.96 0.050
DNMT3B rs1569686 IGFBP3 Site5 G:T 38 5.99 (3.10, 6.51) 40 6.27 (4.66, 6.89) 17 6.88 (6.21, 8.19) 2.96 0.003
DNMT3B rs2424913 IGFBP3 Site1 C:T 36 3.76 (2.40, 5.20) 40 4.61 (3.65, 5.40) 21 5.09 (4.65, 6.41) 2.34 0.019
DNMT3B rs2424913 IGFBP3 Site5 C:T 37 6.00 (3.10, 6.88) 39 6.23 (4.54, 6.79) 21 6.94 (6.21, 8.22) 3.05 0.002
DNMT3B rs2424913 IGFBP3 Mean C:T 38 5.35 (4.72, 6.30) 40 5.60 (5.23, 5.92) 21 6.02 (5.24, 6.77) 2.05 0.041
DNMT3B rs992472 IGFBP3 Site1 C:A 40 4.38 (2.79, 5.27) 40 4.63 (3.65, 5.40) 16 5.23 (3.84, 6.60) 1.99 0.046
DNMT3B rs992472 IGFBP3 Site5 C:A 41 6.00 (4.48, 6.88) 39 6.31 (4.54, 7.00) 16 6.80 (6.11, 8.21) 2.64 0.008
DNMT3B rs2424928 IGFBP3 Site1 T:C 35 3.74 (2.03, 5.04) 39 4.61 (3.59, 5.28) 21 5.09 (4.65, 6.41) 2.56 0.011
DNMT3B rs2424928 IGFBP3 Site5 T:C 36 5.99 (2.98, 6.70) 39 6.23 (4.54, 6.79) 21 6.94 (6.21, 8.22) 3.28 0.001
DNMT3B rs2424928 IGFBP3 Mean T:C 37 5.29 (4.72, 6.27) 39 5.52 (5.22, 5.87) 21 6.02 (5.24, 6.77) 2.26 0.024
† Association between methylation and SNP genotypes was initially tested under an additive model using a non-parametric trend test, unless otherwise stated. ɸ SNPs with
low MAF were tested under a dominant model (with respect to the minor allele) only. Alleles=Major: Minor.
doi: 10.1371/journal.pone.0076506.t002
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Predictors of infant methylation: maternal methylation
and genotypes
Greater variability was demonstrated for measures of global
DNA methylation across the maternal samples compared to
their paired infant samples (Table 3). Small yet notable
differences were observed in methylation levels at CpG sites
mapping to IGF2 and ZNT5 across the maternal and infant
paired samples (Table 3). For both genes methylation levels
were consistently higher in infant compared to maternal
samples. Nonetheless, there was limited pairwise correlation
(rho < 0.6) in methylation levels, both global and loci specific,
demonstrated between mothers and their infants within the 137
mother-infant pairs (Table 3). Similarly, there were no
observable differences in methylation levels at CpG sites
mapping to IGFBP3 between the mothers and their infant pair.
The impact of maternal genotypes on infant methylation
levels was explored and statistically significant findings are
presented in Table 2. See Table S5 in File S1 for all results.
Maternal genotypes at DNMT1 rs2241531 and DNMT3B
rs6058897 were associated with infant global DNA methylation
levels. In both instances, the minor alleles were associated with
lower DNA methylation levels. The minor alleles for the
DNMT3B putative functional SNPs (rs1569686, rs2424913)
and pairwise tagging SNPs rs992472 and rs2424923 were
associated with increased IGFBP3 methylation levels at CpG
sites 1 and 5 in the infant. In particular the associations
involving rs1569686, rs2424913 and rs2424928 with
methylation levels at CpG site 5 were equally significant at p =
0.003, p = 0.002 and p = 0.001, respectively. However, given
the large number of tests performed (10 SNPs x 13 methylation
measures = 130 tests, not accounting for the 3 individual
subgroups) none of these associations remain significant at the
conservative Bonferroni corrected significance threshold of p =
3x10-4 (i.e. 0.05/130). Similarly, these associations are no
longer significant following the less conservative Benjamini &
Hochberg false discovery correction (corrected p-value = 0.13
for each of the three SNPs).
Discussion
The determinants of DNA methylation patterns are the focus
of considerable research interest due to their potential role in
normal development and in pathogenesis [33]. Increasing
evidence suggests that a wide range of environmental factors
can modulate DNA methylation patterns throughout the life-
course [34-39], but there is also some evidence for the
involvement of heritable components in shaping the methylome
[11,27,40,41]. Since the effects of heritable factors on inter-
individual variation in DNA methylation patterns remain largely
unknown, we investigated the impact of genetic variation in
DNMT genes responsible for maintenance (DNMT1) and de
novo methylation (DNMT3B) on both global and locus-specific
DNA methylation in mothers and their newborn infants.
The most consistent observation in this study was the
association of both maternal and infant DNMT3B genotype with
IGFBP3 methylation levels in the infant. In particular, the
functional promoter SNP rs2424913 demonstrated associations
in both instances. Equally significant were the second putative
functional variant rs1569686 and 2 pairwise tagging SNPs
(rs992472, rs2424923), between which strong LD was
exhibited. Rs2424913 has previously been implicated in altered
DNMT3B promoter activity and lung cancer risk [16].
Specifically, the minor allele was associated with increased
promoter activity, which the authors postulated may lead to
aberrant hypermethylation leading to disease risk. Subsequent
studies have demonstrated association between DNMT3B
promoter polymorphisms and hypermethylation of DNA repair
and tumour suppressor genes [19,25]. However, these studies
tested proxies for the rs2424913 polymorphism. Although the
current findings of increased IGFBP3 methylation with carriage
of the minor rs2424913 variant are consistent with the
hypothesis, they did not reach statistical significance following
correction for multiple testing. Furthermore, the effect of this
SNP on IGFBP3 methylation is relatively modest and could
reflect technical variability within the Pyrosequencing assay.
Table 3. Comparison of methylation levels in maternal-infant pairs.
 Median (25%, 75%) Methylation Mother-Infant Comparison† Mother-Infant Correlationɸ
Methylation locus N* Mothers Infants Paired Difference z p rho p
Global, ratio 59 0.34 (0.28, 0.62) 0.35 (0.30, 0.39) 0.03 (-0.06, 0.26) 2.48 0.0130 0.18 0.1650
IGF2 Site1 115 41.81 (38.95, 45.15) 45.56 (41.42, 47.64) -2.52 (-6.14, 2.18) -3.64 0.0003 -0.04 0.6572
IGF2 Site2 118 49.22 (46.32, 52.68) 51.97 (48.50, 54.24) -2.23 (-6.29, 2.45) -2.86 0.0043 -0.01 0.9566
IGF2 Site3 113 46.60 (44.31, 49.94) 49.89 (46.61, 52.22) -1.93 (-5.49, 1.72) -3.06 0.0022 0.01 0.9055
IGFBP3 Site1 89 4.81 (3.06, 5.88) 4.65 (3.00, 5.39) 0.07 (-1.28, 1.46) 0.52 0.6062 0.30 0.0037
IGFBP3 Site2 91 5.73 (4.91, 7.08) 5.68 (5.12, 6.44) 0.10 (-0.92, 1.50) 0.71 0.4750 0.08 0.4239
IGFBP3 Site3 90 4.38 (3.60, 5.21) 4.34 (3.82, 4.94) 0.02 (-1.23, 1.13) 0.29 0.7705 0.17 0.1117
IGFBP3 Site4 90 7.55 (5.85, 8.63) 7.12 (6.12, 8.03) 0.38 (-1.73, 2.44) 1.29 0.1979 0.25 0.0198
IGFBP3 Site5 89 5.40 (4.20, 6.58) 6.23 (5.29, 7.15) -0.21 (-2.67, 0.96) -1.79 0.0738 0.11 0.2903
ZNT5 Site2 74 92.00 (81.00, 95.50) 95.50 (89.50, 97.50) -2.50 (-12.50, 2.00) -3.32 0.0009 0.10 0.4063
ZNT5 Site3 75 92.00 (82.50, 96.00) 97.00 (90.00, 99.50) -4.00 (-12.50, 0.50) -3.06 0.0022 0.03 0.7747
† Comparison between maternal and infant methylation levels were made by non-parametric Wilcoxon signed-rank tests. ɸ Correlations between maternal and infant
methylation levels were assessed by non-parametric Spearman’s rank. * Reflects the number of paired samples with available methylation data.
doi: 10.1371/journal.pone.0076506.t003
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It was anticipated that genetic variation within the DNMT
genes would have a more wide spread effect upon global,
compared to loci-specific, DNA methylation. Two potential
associations were demonstrated between maternal genotype
(DNMT1 rs2241531, DNMT3B rs6058897) and infant global
methylation. However, these findings were not robust to
correction for multiple testing.
The presence of both maternal and infant samples is a
particular strength of the current study as it would have allowed
for comparisons to be drawn between the effects of heritable
factors upon DNA methylation at different time points. In the
absence of robust associations however, we can consider
differences in the methylation distributions between the
maternal-infant pairs. In keeping with the hypothesis that
environmental and lifestyle influences upon DNA methylation
increase over time, global DNA methylation did appear more
variable in the maternal compared to infant samples in the
study cohort. However, for reasons that are unclear, the LUMA
global methylation assays were less successful in the maternal
samples compared to the infant samples. Substantial efforts
were taken to ensure a high quality of DNA with triplicate
digests for each sample. Furthermore, inspection of the data
identified no significant differences between individuals with
and without successful global methylation measures in terms of
DNMT genotypes and demographic characteristics (i.e.
maternal age, smoking status, folate titre and social economic
status) (data not shown), suggesting no systematic bias had
occurred. Nonetheless, further investigations may be warranted
utilising an alternative measure of global DNA methylation.
In conclusion, the observations from this study provide
limited evidence to suggest that common variants in the
DNMT1 and DNMT3B genes influence inter-individual variation
in global DNA methylation and the three loci investigated here.
Further work could include a more comprehensive investigation
of genome-wide genetic and epigenetic factors as this study
was limited by taking a targeted approach to investigating both
elements.
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